• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 490399 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1418904830 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1418904830 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Acorda Therapeutics Shares Sinking Lower, Down 2.6%

Published on Wed, 05/01/2013 - 10:30
By Adrienne Chilton

Acorda Therapeutics (NASDAQ:ACOR), a company whose shares are moving quickly, is trading 2.6% lower to $38.54. The Dow Jones Industrial Average is now trading 0.4% lower to 14,781 and the S&P is trading 0.4% lower to 1,591.

Acorda Therapeutics (NASDAQ:ACOR) is currently priced 16.6% above its average consensus analyst price target of $32.14. The stock should find initial support at its 50-day moving average (MA) of $32.69 and further support at its 200-day MA of $27.13.

In the past 52 weeks, shares of Acorda Therapeutics have traded between a low of $21.04 and a high of $40.87 and are now at $38.54, which is 83% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.8% while the 200-day MA has risen 0.7%.

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Shares of ViewPoint Financial Fall to a ...

ViewPoint Financial (NASDAQ:VPFG) traded today at a new 52-week low of $21.11. This ne ...

Shares of UQM Technologies Have Fallen B...

Shares of UQM Technologies (AMEX:UQM) traded at a new 52-week low today of $0.86. Appr ...

Shares of Terex Have Fallen Below Previo...

Shares of Terex (NYSE:TEX) traded at a new 52-week low today of $25.40. So far today a ...

Sun Communities: The Winning Streak Cont...

Shares of Sun Communities (NYSE:SUI) traded at a new 52-week high today of $60.92. So ...

Watch for Continued Losses in Shares of ...

Renesola (NYSE:SOL) traded today at a new 52-week low of $1.21. Approximately 1.1 mill ...

Solera Holdings Looks to Continue to Tra...

Solera Holdings (NYSE:SLH) traded today at a new 52-week low of $45.69. Approximately ...

SAIFUN SEMICONDUCTOR Looks to Continue t...

SAIFUN SEMICONDUCTOR (NASDAQ:SFUN) traded today at a new 52-week low of $6.78. So far ...

Shares of Select Comfort Rise Above Prev...

Shares of Select Comfort (NASDAQ:SCSS) traded at a new 52-week high today of $27.13. T ...